Your partner
in urogenital
preclinical research
Your partner
in uro-genital
pre-clinical research
Therapeutic Areas
Urology
A wide range of preclinical models of urological diseases.
Nephrology
An expertise on preclinical models for kidney pathologies
Oncology
From cells and organoids to human tumors-xenografts models.
Gynecology
A wide range of preclinical models of gynecological diseases.
Andrology
A wide range of preclinical models of males diseases.
Gastroenterology
An expertise on major gastrointestinal diseases.
Our
Platform
Our Platform
With an optimized platform and a pharmaceutical industry level of quality, Urosphere’s Platform offers over a decade of expertise and know-how in preclinical drug development through its in vivo and in vitro models.
News & Publications
News &
Publications
A new tumorgraft panel to accelerate precision medicine in prostate cancer
Béraud C. et al., 2023. Frontiers in Oncology, 13
Experimental in vivo model to evaluate the impact of Cernitin™ on pain response on induced chronic bladder inflammation
Augé C. et al., 2022. Scandinavian Journal of Urology, 56 (4)
Integrated molecular and pharmacological characterization of patient derived xenografts from bladder and ureteral cancers identifies new potential therapies
Lang H. et al., 2022. Frontiers in Oncology, 12
Research &
Development
Research & Development
Our Partners
Our Company
As a member of the drug discovery value chain, Urosphere can support your project. Our experts and platforms are dedicated to meeting your needs. Our aim is to understand your challenges and objectives to develop customized solutions together.
